Corrigendum to "Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study" [Eur J Cancer 196 (2024) 113424]
1 Amsterdam UMC Location VU Medical Center, Department of Medical Oncology, Amsterdam, the Netherlands.
2 Amsterdam UMC Location VU Medical Center, Department of Endocrinology and Metabolism, Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.
3 Amsterdam UMC Location VU Medical Center, Department of Surgery, Amsterdam, the Netherlands.
4 Amsterdam UMC Location VU Medical Center, Department of Radiation Oncology and Cancer Center Amsterdam, Amsterdam, the Netherlands.
5 Maxima Medical Center, Department of Internal Medicine, Eindhoven, the Netherlands; Maastricht University, CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, the Netherlands; Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands.
6 Maxima Medical Center, Department of Internal Medicine, Eindhoven, the Netherlands; Maastricht University, CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, the Netherlands; Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
7 Leiden University Medical Center, Department of Medical Oncology, Leiden, the Netherlands.
8 Leiden University Medical Center, Center of Endocrine Tumours, Division of Endocrinology, Department of Internal Medicine, Leiden, the Netherlands.
9 Amsterdam UMC Location VU Medical Center, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands. Electronic address: c.menke@amsterdamumc.nl.